Published in Biophys J on December 01, 1995
Structure modeling of all identified G protein-coupled receptors in the human genome. PLoS Comput Biol (2006) 2.40
Visualisation and integration of G protein-coupled receptor related information help the modelling: description and applications of the Viseur program. J Comput Aided Mol Des (1999) 1.46
Opioid receptor three-dimensional structures from distance geometry calculations with hydrogen bonding constraints. Biophys J (1998) 1.38
The variable and conserved interfaces of modeled olfactory receptor proteins. Protein Sci (1999) 1.34
First principles predictions of the structure and function of g-protein-coupled receptors: validation for bovine rhodopsin. Biophys J (2004) 1.30
Amide vibrations are delocalized across the hydrophobic interface of a transmembrane helix dimer. Proc Natl Acad Sci U S A (2006) 1.17
The transmembrane 7-alpha-bundle of rhodopsin: distance geometry calculations with hydrogen bonding constraints. Biophys J (1997) 1.10
Molecular dynamics of individual alpha-helices of bacteriorhodopsin in dimyristol phosphatidylocholine. I. Structure and dynamics. Biophys J (1997) 1.10
Molecular dynamics simulations of individual alpha-helices of bacteriorhodopsin in dimyristoylphosphatidylcholine. II. Interaction energy analysis. Biophys J (1998) 1.02
Calculation of rigid-body conformational changes using restraint-driven Cartesian transformations. Biophys J (2001) 0.95
A sequence and structural study of transmembrane helices. J Comput Aided Mol Des (2001) 0.94
Modeling and docking the endothelin G-protein-coupled receptor. Biophys J (2000) 0.92
Optimal bundling of transmembrane helices using sparse distance constraints. Protein Sci (2004) 0.86
BUNDLE: a program for building the transmembrane domains of G-protein-coupled receptors. J Comput Aided Mol Des (1998) 0.84
Molecular modeling of the human vasopressin V2 receptor/agonist complex. J Comput Aided Mol Des (1998) 0.84
Using experimental information to produce a model of the transmembrane domain of the ion channel phospholamban. Biophys J (1998) 0.83
Molecular modeling of interactions of the non-peptide antagonist YM087 with the human vasopressin V1a, V2 receptors and with oxytocin receptors. J Comput Aided Mol Des (2001) 0.81
Molecular dynamics simulation approach for the prediction of transmembrane helix-helix heterodimers assembly. Eur Biophys J (2007) 0.79
The pore-lining region of shaker voltage-gated potassium channels: comparison of beta-barrel and alpha-helix bundle models. Biophys J (1997) 0.79
Molecular modelling studies on the ORL1-receptor and ORL1-agonists. J Comput Aided Mol Des (2003) 0.79
Protein structures from domain packing--a game of twenty questions? Biophys J (1995) 0.75
The Protein Data Bank: a computer-based archival file for macromolecular structures. J Mol Biol (1977) 90.57
Optimization by simulated annealing. Science (1983) 71.02
Model for the structure of bacteriorhodopsin based on high-resolution electron cryo-microscopy. J Mol Biol (1990) 13.72
Three-dimensional model of purple membrane obtained by electron microscopy. Nature (1975) 13.28
The helical hydrophobic moment: a measure of the amphiphilicity of a helix. Nature (1982) 5.01
Path of the polypeptide in bacteriorhodopsin. Proc Natl Acad Sci U S A (1980) 4.76
Transmembrane protein structure: spin labeling of bacteriorhodopsin mutants. Science (1990) 4.07
The molecular basis of visual excitation. Nature (1968) 3.96
The probable arrangement of the helices in G protein-coupled receptors. EMBO J (1993) 3.57
Effect of carboxylic acid side chains on the absorption maximum of visual pigments. Science (1989) 3.44
Projection structure of rhodopsin. Nature (1993) 3.41
Structure and function of G protein-coupled receptors. Annu Rev Biochem (1994) 3.36
Structure and function in rhodopsin. 7. Point mutations associated with autosomal dominant retinitis pigmentosa. Biochemistry (1994) 2.88
Constitutively active mutants of rhodopsin. Neuron (1992) 2.84
Substitution of amino acids Asp-85, Asp-212, and Arg-82 in bacteriorhodopsin affects the proton release phase of the pump and the pK of the Schiff base. Proc Natl Acad Sci U S A (1990) 2.80
Determinants of visual pigment absorbance: identification of the retinylidene Schiff's base counterion in bovine rhodopsin. Biochemistry (1990) 2.79
Bacteriorhodopsin, a membrane protein that uses light to translocate protons. J Biol Chem (1988) 2.57
Spectral tuning of pigments underlying red-green color vision. Science (1991) 2.24
In vitro mutagenesis and the search for structure-function relationships among G protein-coupled receptors. Biochem J (1992) 2.14
Trigger and amplification mechanisms in visual phototransduction. Annu Rev Biophys Biophys Chem (1985) 2.12
Solid-state 13C NMR detection of a perturbed 6-s-trans chromophore in bacteriorhodopsin. Biochemistry (1985) 2.09
Heterozygous missense mutation in the rhodopsin gene as a cause of congenital stationary night blindness. Nat Genet (1993) 1.93
Assignment of fingerprint vibrations in the resonance Raman spectra of rhodopsin, isorhodopsin, and bathorhodopsin: implications for chromophore structure and environment. Biochemistry (1987) 1.81
FTIR difference spectroscopy of bacteriorhodopsin: toward a molecular model. J Bioenerg Biomembr (1992) 1.81
Mapping of the amino acids in membrane-embedded helices that interact with the retinal chromophore in bovine rhodopsin. J Biol Chem (1991) 1.80
Constitutive activation of opsin: influence of charge at position 134 and size at position 296. Biochemistry (1993) 1.80
Orientation of the bacteriorhodopsin chromophore probed by polarized Fourier transform infrared difference spectroscopy. Biochemistry (1986) 1.76
On the mechanism of wavelength regulation in visual pigments. Photochem Photobiol (1985) 1.74
Rhodopsin mutation G90D and a molecular mechanism for congenital night blindness. Nature (1994) 1.73
Determinants of visual pigment absorbance: role of charged amino acids in the putative transmembrane segments. Biochemistry (1990) 1.72
Specific labelling of the protein and lipid on the extracellular surface of purple membrane. J Mol Biol (1978) 1.71
Low resolution structure of bovine rhodopsin determined by electron cryo-microscopy. Biophys J (1995) 1.70
Replacement of leucine-93 by alanine or threonine slows down the decay of the N and O intermediates in the photocycle of bacteriorhodopsin: implications for proton uptake and 13-cis-retinal----all-trans-retinal reisomerization. Proc Natl Acad Sci U S A (1991) 1.69
Nuclear magnetic resonance study of the Schiff base in bacteriorhodopsin: counterion effects on the 15N shift anisotropy. Biochemistry (1989) 1.69
Design of a discriminating fingerprint for G-protein-coupled receptors. Protein Eng (1993) 1.68
Three-dimensional models of neurotransmitter G-binding protein-coupled receptors. Mol Pharmacol (1991) 1.63
Bacteriorhodopsin mutants containing single tyrosine to phenylalanine substitutions are all active in proton translocation. Proc Natl Acad Sci U S A (1987) 1.58
Modeling alpha-helical transmembrane domains: the calculation and use of substitution tables for lipid-facing residues. Protein Sci (1993) 1.53
High-sensitivity neutron diffraction of membranes: Location of the Schiff base end of the chromophore of bacteriorhodopsin. Proc Natl Acad Sci U S A (1988) 1.48
Orientation of retinal in bacteriorhodopsin as studied by cross-linking using a photosensitive analog of retinal. J Biol Chem (1982) 1.43
A method for alpha-helical integral membrane protein fold prediction. Proteins (1994) 1.42
Bacteriorhodopsin mutants containing single substitutions of serine or threonine residues are all active in proton translocation. J Biol Chem (1991) 1.41
Images of purple membrane at 2.8 A resolution obtained by cryo-electron microscopy. J Mol Biol (1988) 1.38
A neutron diffraction study on the location of the polyene chain of retinal in bacteriorhodopsin. Proc Natl Acad Sci U S A (1985) 1.31
Orientation of retinal in bovine rhodopsin determined by cross-linking using a photoactivatable analog of 11-cis-retinal. J Biol Chem (1990) 1.30
Molecular modeling of adenosine receptors. I. The ligand binding site on the A1 receptor. Drug Des Discov (1992) 1.25
Distance-constrained molecular docking by simulated annealing. Protein Eng (1990) 1.24
Tertiary structure of bacteriorhodopsin. Positions and orientations of helices A and B in the structural map determined by neutron diffraction. J Mol Biol (1989) 1.24
Modeling of G-protein-coupled receptors: application to dopamine, adrenaline, serotonin, acetylcholine, and mammalian opsin receptors. J Med Chem (1992) 1.23
Locations of Arg-82, Asp-85, and Asp-96 in helix C of bacteriorhodopsin relative to the aqueous boundaries. Proc Natl Acad Sci U S A (1991) 1.20
Propylbenzilylcholine mustard labels an acidic residue in transmembrane helix 3 of the muscarinic receptor. J Biol Chem (1989) 1.15
Three-dimensional modelling of G protein-linked receptors. Trends Pharmacol Sci (1990) 1.14
Location of the cyclohexene ring of the chromophore of bacteriorhodopsin by neutron diffraction with selectively deuterated retinal. Proc Natl Acad Sci U S A (1986) 1.13
Transmembrane location of retinal in bacteriorhodopsin by neutron diffraction. Biochemistry (1990) 1.09
Analysis of C alpha geometry in protein structures. Proteins (1994) 1.08
The ligand-binding domain of rhodopsin and other G protein-linked receptors. J Bioenerg Biomembr (1992) 1.06
Low-temperature solid-state 13C NMR studies of the retinal chromophore in rhodopsin. Biochemistry (1987) 1.05
Simulated annealing approach to the study of protein structures. Protein Eng (1991) 1.05
Three-dimensional structure for the beta 2 adrenergic receptor protein based on computer modeling studies. J Mol Biol (1992) 1.04
Modeling of transmembrane seven helix bundles. Protein Eng (1993) 1.03
Ultraviolet-visible transient spectroscopy of bacteriorhodopsin mutants. Evidence for two forms of tyrosine-185----phenylalanine. J Biol Chem (1990) 1.02
The evolution and structure of aminergic G protein-coupled receptors. Receptors Channels (1994) 1.01
An analysis of the periodicity of conserved residues in sequence alignments of G-protein coupled receptors. Implications for the three-dimensional structure. FEBS Lett (1989) 0.98
Fourier transform infrared difference spectroscopy of rhodopsin mutants: light activation of rhodopsin causes hydrogen-bonding change in residue aspartic acid-83 during meta II formation. Biochemistry (1993) 0.97
Solid-state NMR studies of the mechanism of the opsin shift in the visual pigment rhodopsin. Biochemistry (1990) 0.97
Modeling of human thromboxane A2 receptor and analysis of the receptor-ligand interaction. J Med Chem (1993) 0.94
Two hypotheses--one answer. Sequence comparison does not support an evolutionary link between halobacterial retinal proteins including bacteriorhodopsin and eukaryotic G-protein-coupled receptors. FEBS Lett (1994) 0.93
On the use of the transmembrane domain of bacteriorhodopsin as a template for modeling the three-dimensional structure of guanine nucleotide-binding regulatory protein-coupled receptors. Proc Natl Acad Sci U S A (1992) 0.92
Signal transduction by a 5-HT2 receptor: a mechanistic hypothesis from molecular dynamics simulations of the three-dimensional model of the receptor complexed to ligands. J Med Chem (1993) 0.92
Alpha-helix folding by Monte Carlo simulated annealing in isolated C-peptide of ribonuclease A. Protein Eng (1991) 0.91
Applications of simulated annealing to peptides. Biopolymers (1990) 0.91
SQUID: a program for the analysis and display of data from crystallography and molecular dynamics. J Mol Graph (1992) 0.89
Substitution of amino acids in helix F of bacteriorhodopsin: effects on the photochemical cycle. Biochemistry (1989) 0.88
A model of the adrenergic beta-2 receptor and binding sites for agonist and antagonist. Drug Des Discov (1992) 0.88
Binding-site modeling of the muscarinic m1 receptor: a combination of homology-based and indirect approaches. J Med Chem (1993) 0.88
Light-stable rhodopsin. II. An opsin mutant (TRP-265----Phe) and a retinal analog with a nonisomerizable 11-cis configuration form a photostable chromophore. J Biol Chem (1992) 0.88
Characterization of rhodopsin-transducin interaction: a mutant rhodopsin photoproduct with a protonated Schiff base activates transducin. Biochemistry (1994) 0.88
Movement of the retinylidene Schiff base counterion in rhodopsin by one helix turn reverses the pH dependence of the metarhodopsin I to metarhodopsin II transition. J Biol Chem (1993) 0.88
Molecular dynamics of the 5-HT1a receptor and ligands. Protein Eng (1993) 0.83
Molecular dynamics of dopamine at the D2 receptor. Proc Natl Acad Sci U S A (1991) 0.82
A reduced representation of proteins for use in restraint satisfaction calculations. Proteins (1993) 0.81
Structural model of antagonist and agonist binding to the angiotensin II, AT1 subtype, G protein coupled receptor. Chem Biol (1994) 0.81
Met-145 is a key residue in the dark adaptation of bacteriorhodopsin homologs. Biophys J (1994) 0.81
Sequence homology between bacteriorhodopsin and G-protein coupled receptors: exon shuffling or evolution by duplication? FEBS Lett (1993) 0.80
Sequence divergence analysis for the prediction of seven-helix membrane protein structures: II. A 3-D model of human rhodopsin. Protein Eng (1994) 0.80
A model for the C5a receptor and for its interaction with the ligand [corrected]. Protein Eng (1991) 0.79
Beta-sheet folding of fragment (16-36) of bovine pancreatic trypsin inhibitor as predicted by Monte Carlo simulated annealing. Protein Eng (1992) 0.76
Molecular basis of agonism and antagonism in the oestrogen receptor. Nature (1997) 9.09
Hydrogen bonding in globular proteins. Prog Biophys Mol Biol (1984) 6.58
Structural model of ATP-binding proteins associated with cystic fibrosis, multidrug resistance and bacterial transport. Nature (1990) 6.41
The structure of 2Zn pig insulin crystals at 1.5 A resolution. Philos Trans R Soc Lond B Biol Sci (1988) 3.30
Glycosaminoglycans interact selectively with chemokines and modulate receptor binding and cellular responses. Biochemistry (1999) 3.07
Structure of the ligand-binding domain of oestrogen receptor beta in the presence of a partial agonist and a full antagonist. EMBO J (1999) 2.81
Income and the midlife peak in common mental disorder prevalence. Psychol Med (2010) 2.13
Structural insights into the mode of action of a pure antiestrogen. Structure (2001) 1.92
Identification of a glycosaminoglycan binding surface on human interleukin-8. Biochemistry (1998) 1.71
Locating interaction sites on proteins: the crystal structure of thermolysin soaked in 2% to 100% isopropanol. Proteins (1999) 1.46
Experimental and computational mapping of the binding surface of a crystalline protein. Protein Eng (2001) 1.35
Structure of the protein tyrosine kinase domain of C-terminal Src kinase (CSK) in complex with staurosporine. J Mol Biol (1999) 1.32
Structure and function of endoglucanase V. Nature (1993) 1.31
The x-ray crystal structure of phosphomannose isomerase from Candida albicans at 1.7 angstrom resolution. Nat Struct Biol (1996) 1.27
Understanding the mechanism of ice binding by type III antifreeze proteins. J Mol Biol (2001) 1.22
HOOK: a program for finding novel molecular architectures that satisfy the chemical and steric requirements of a macromolecule binding site. Proteins (1994) 1.17
Analysis of C alpha geometry in protein structures. Proteins (1994) 1.08
Ligand-induced conformational change in penicillin acylase. J Mol Biol (1998) 1.07
Drug-like annotation and duplicate analysis of a 23-supplier chemical database totalling 2.7 million compounds. J Chem Inf Comput Sci (2004) 1.07
Structure and mechanism of the oestrogen receptor. Biochem Soc Trans (2003) 1.07
A structural biologist's view of the oestrogen receptor. J Steroid Biochem Mol Biol (2000) 1.02
Frailty in older inpatients: what physicians need to know. QJM (2012) 0.99
Insulin's structural behavior and its relation to activity. Biopolymers (1983) 0.99
Molecular structure of insulin: the insulin monomer and its assembly. Br Med Bull (1989) 0.98
Relating structure to thermodynamics: the crystal structures and binding affinity of eight OppA-peptide complexes. Protein Sci (1999) 0.94
Investigating the high affinity and low sequence specificity of calmodulin binding to its targets. J Mol Biol (1994) 0.93
Characterising the geometric diversity of functional groups in chemical databases. J Comput Aided Mol Des (1995) 0.92
Conformational change in the activation of lipase: an analysis in terms of low-frequency normal modes. Protein Sci (1998) 0.92
Structural aspects of agonism and antagonism in the oestrogen receptor. Biochem Soc Trans (2000) 0.91
Domain motions in dihydrofolate reductase: a molecular dynamics study. J Mol Biol (1997) 0.90
Modeling of the three-dimensional structure of the human melanocortin 1 receptor, using an automated method and docking of a rigid cyclic melanocyte-stimulating hormone core peptide. J Mol Graph Model (1997) 0.89
Combined biophysical and biochemical information confirms arrangement of transmembrane helices visible from the three-dimensional map of frog rhodopsin. J Mol Biol (1998) 0.86
Crystallization and preliminary X-ray diffraction study of a chimaeric Fab' fragment of antibody binding tumour cells. J Mol Biol (1991) 0.86
Virtual screening in structure-based drug discovery. Mini Rev Med Chem (2004) 0.85
Automated modelling of the transmembrane region of G-protein coupled receptor by Swiss-model. Receptors Channels (1996) 0.84
The solution structure of echistatin: evidence for disulphide bond rearrangement in homologous snake toxins. Protein Eng (1992) 0.84
Frailty: a key indicator to minimize inappropriate medication in older people. QJM (2013) 0.84
Using experimental information to produce a model of the transmembrane domain of the ion channel phospholamban. Biophys J (1998) 0.83
Towards structural models of molecular recognition in olfactory receptors. Biochimie (1998) 0.83
Apomyoglobin as a molecular recognition surface: expression, reconstitution and crystallization of recombinant porcine myoglobin in Escherichia coli. Protein Eng (1988) 0.82
Design of a fragment library that maximally represents available chemical space. J Comput Aided Mol Des (2011) 0.81
Nasoethmoidal meningoencephalocele. Arch Otolaryngol (1974) 0.81
A reduced representation of proteins for use in restraint satisfaction calculations. Proteins (1993) 0.81
Crystal structure of a chimeric Fab' fragment of an antibody binding tumour cells. J Mol Biol (1992) 0.81
Structure of Fab hGR-2 F6, a competitive antagonist of the glucagon receptor. Acta Crystallogr D Biol Crystallogr (2000) 0.80
The design, synthesis, and evaluation of novel conformationally rigid analogues of sialyl Lewis(x). Bioorg Med Chem (1998) 0.80
Comparison of two frailty measures in the Conselice Study of Brain Ageing. J Nutr Health Aging (2010) 0.79
Determination of the crystal structure of recombinant pig myoglobin by molecular replacement and its refinement. Acta Crystallogr B (1990) 0.78
EXTRACT: a program to extract three-dimensional coordinates from stereo diagrams of proteins. J Mol Graph (1995) 0.78
Solid-phase binding assay to study interaction of chemokines with glycosaminoglycans. Methods Enzymol (1997) 0.77
Prescribing for older people discharged from the acute sector to residential aged-care facilities. Intern Med J (2014) 0.77
Crystallization and preliminary X-ray analysis of Candida albicans phosphomannose isomerase. J Mol Biol (1994) 0.76
Adipose tissue, obesity and insulin. Prog Med Chem (1980) 0.75
Pancreatic insufficiency and weight loss in older patients. QJM (2004) 0.75
Impact of Post-Acute Transition Care for Frail Older People: A Prospective Study. J Frailty Aging (2013) 0.75
Model structures and action of interleukin 1 and its antagonist. Protein Eng (1993) 0.75
AqueA questionnaire for medical conditions in dental patients. Dent Mag Oral Top (1970) 0.75
Letter to the Editor: Are Prescribing Indicators Essentially Representing the Frail Older Population? J Frailty Aging (2013) 0.75
The composition and fluidity of adipocyte membranes prepared from young and adult rats. Biochim Biophys Acta (1980) 0.75
Baseline Vulnerability and Inpatient Frailty Status in Relation to Adverse Outcomes in a Surgical Cohort. J Frailty Aging (2016) 0.75
Feasibility of Using Information Derived from a Care Partner to Develop a Frailty Index Based on Comprehensive Geriatric Assessment. J Frailty Aging (2013) 0.75
Sinusule: timed-release therapy in allergic rhinitis, with human in-vivo release rates and clinical statistics. Curr Ther Res Clin Exp (1967) 0.75
Exploring molecular structure by virtual reality. Trends Biotechnol (1995) 0.75
Characterization of the uptake of 1,6-diphenylhexa-1,3,5-triene by adipocyte membranes [proceedings]. Biochem Soc Trans (1979) 0.75
Surgical treatment of aortic embolism in the cat. J Am Vet Med Assoc (1966) 0.75